Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation.
Geller RB, Devine SM, O'Toole K, Persons L, Keller J, Mauer D, Holland HK, Dix SP, Piotti M, Redei I, Connaghan G, Heffner LT, Hillyer CD, Waller EK, Winton EF, Wingard JR. Geller RB, et al. Among authors: keller j. Bone Marrow Transplant. 1997 Aug;20(3):219-25. doi: 10.1038/sj.bmt.1700874. Bone Marrow Transplant. 1997. PMID: 9257890 Free PMC article.
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
Devine SM, Geller RB, Lin LB, Dix SP, Holland HK, Maurer D, O'Toole K, Keller J, Connaghan DG, Heffner LT, Hillyer CD, Rodey GE, Winton EF, Maher RM, Fitzsimmons WE, Wingard JR. Devine SM, et al. Among authors: keller j. Biol Blood Marrow Transplant. 1997 Apr;3(1):25-33. Biol Blood Marrow Transplant. 1997. PMID: 9209738 Clinical Trial.
Donor work-up and transport of bone marrow--recommendations and requirements for a standardized practice throughout the world from the Donor Registries and Quality Assurance Working Groups of the World Marrow Donor Association (WMDA).
Cleaver SA, Warren P, Kern M, Hurley CK, Raffoux C, Keller J, Kiesel U, Koza V, Marry E, Mitterschiffthaler A, Nakamura M, Okah CT, Persson U, Radde-Stepaniak T, Ranson L, Raymond J, do Rosario Sancho M, Varla-Leftherioti M, Wiegand T, Winterhager JM, Woodfield DG. Cleaver SA, et al. Among authors: keller j. Bone Marrow Transplant. 1997 Oct;20(8):621-9. doi: 10.1038/sj.bmt.1700943. Bone Marrow Transplant. 1997. PMID: 9383224
Haploidentical transplantation using G-CSF-mobilized T-cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated with favorable outcomes.
Bhamidipati PK, DiPersio JF, Stokerl-Goldstein K, Rashidi A, Gao F, Uy GL, Westervelt P, Vij R, Schroeder MA, Abboud CN, Keller JW, Fehniger TA, Romee R. Bhamidipati PK, et al. Among authors: keller jw. Bone Marrow Transplant. 2014 Aug;49(8):1124-6. doi: 10.1038/bmt.2014.108. Epub 2014 May 19. Bone Marrow Transplant. 2014. PMID: 24842528 No abstract available.
The molecular mechanism of on-demand sterol biosynthesis at organelle contact sites.
Zung N, Aravindan N, Boshnakovska A, Valenti R, Preminger N, Jonas F, Yaakov G, Willoughby MM, Homberg B, Keller J, Kupervaser M, Dezorella N, Dadosh T, Wolf SG, Itkin M, Malitsky S, Brandis A, Barkai N, Fernández-Busnadiego R, Reddi AR, Rehling P, Rapaport D, Schuldiner M. Zung N, et al. Among authors: keller j. bioRxiv [Preprint]. 2024 May 12:2024.05.09.593285. doi: 10.1101/2024.05.09.593285. bioRxiv. 2024. PMID: 38766039 Free PMC article. Preprint.
3,424 results